Cargando…
Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues
BACKGROUND: Adoptive immunotherapy offers great potential for treating many types of cancer but its clinical application is hampered by cross-reactive T cell responses in healthy human tissues, representing serious safety risks for patients. We previously developed a computational tool called Expito...
Autores principales: | Jaravine, Victor, Mösch, Anja, Raffegerst, Silke, Schendel, Dolores J., Frishman, Dmitrij |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745885/ https://www.ncbi.nlm.nih.gov/pubmed/29282079 http://dx.doi.org/10.1186/s12885-017-3854-8 |
Ejemplares similares
-
Machine Learning for Cancer Immunotherapies Based on Epitope Recognition by T Cell Receptors
por: Mösch, Anja, et al.
Publicado: (2019) -
PROMPT: a protein mapping and comparison tool
por: Schmidt, Thorsten, et al.
Publicado: (2006) -
TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes
por: Zhang, Guanglan, et al.
Publicado: (2021) -
Isolation of antigen-specific CD8+ T lymphocytes in vitro and in vivo
por: Wehner, Carina, et al.
Publicado: (2013) -
Differential expression analysis of human endogenous retroviruses based on ENCODE RNA-seq data
por: Haase, Kerstin, et al.
Publicado: (2015)